Delivery Order SPE2DB22D2206-SPE2DB22FDY39
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,558,165,058 units of the pharmaceutical NORVASC 10 MG TABLET 90S. The $181,695.58 order was placed on August 19, 2022 with an expected completion date of August 22, 2022. This award was not set aside for any specific business type. AmerisourceBergen Drug Corp is a prime contractor that provides pharmaceutical products and...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply NORVASC 10 MG TABLET 90S. The $158,270.08 contract does not have a set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, is a prime contractor that provides pharmaceutical products and related distribution services to various U.S. government agencies, including the Department of Defense. This delivery...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $10,726.53 contract is for the supply of NORVASC 2.5 MG TABLET 90S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NORVASC 2.5 mg tablets. The contract has a firm-fixed price of $1,792.72 and an ultimate completion date of August 28, 2024. It was awarded as a delivery order, with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract, which is likely part of a larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $2,244.76 firm fixed price delivery order is for the supply of NORVASC 10 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,167.46 firm fixed price delivery order is for the supply of NORVASC 5 MG TABLET 90S, a pharmaceutical product, in support of military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical firm Amerisourcebergen Corporation. The $119,298.45 order is for the supply of Norvasc 10mg tablets to support DLA Troop Support Medical programs and facilities. As a prime contractor, Amerisourcebergen Drug Corp has an extensive history of providing a range of pharmaceutical products and medical supplies to the Department of Defense....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $6,615 to Amerisourcebergen Drug Corporation. The order is for 100 tablets of the pharmaceutical Norvasc 5 mg and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 10, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will supply the medication to support the Defense Logistics Agency's logistics and procurement programs. No subcontractors or...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,296.53, is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that runs through December 2022. This award is not designated as a set-aside contract. AmerisourceBergen holds a larger...
- <p>The Defense Logistics Agency awarded a $346,773.43 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 4558513589 NORVASC 10 MG TABLET 90S. Amerisourcebergen Drug Corp Corporate Office Division, a division of Amerisourcebergen Corporation, will provide the pharmaceutical products from its place of performance in Conshohocken, Pennsylvania under the contract starting on September 19, 2022 and ending on September 20, 2022.</p>
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB22FDY39Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 90 tablets of NORVASC 10 MG for $215,011.72. The order was placed on July 21, 2022 and is scheduled for completion on July 22, 2022. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp is a prime contractor that has received numerous awards from DLA to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. The company also holds an indefinite delivery contract with the FBI Headquarters Division to supply medical supplies and prescription medications, with a potential value of $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $215.0k | 7/21/22 |